104 related articles for article (PubMed ID: 28738376)
1. Evaluation of the Impact of Cognitive Training on Quality of Life in Patients with Multiple Sclerosis.
Grasso MG; Broccoli M; Casillo P; Catani S; Pace L; Pompa A; Rizzi F; Troisi E
Eur Neurol; 2017; 78(1-2):111-117. PubMed ID: 28738376
[TBL] [Abstract][Full Text] [Related]
2. Impact of Anxious and/or Depressive Reactive State on the Effectiveness of Rehabilitation of Patients with Multiple Sclerosis.
Bućma T; Sladojević I; Arambašić LT; Jeremić N; Tomić B
Medicina (Kaunas); 2024 Jun; 60(6):. PubMed ID: 38929558
[No Abstract] [Full Text] [Related]
3. Cognitive phenotypes predict response to restorative cognitive rehabilitation in multiple sclerosis.
Ziccardi S; Fuchs T; Dwyer MG; Zivadinov R; Hulst HE; Calabrese M; Benedict RH
Mult Scler; 2024 Mar; 30(3):448-452. PubMed ID: 37942544
[TBL] [Abstract][Full Text] [Related]
4. Enhancing the Quality of Life of Patients with Multiple Sclerosis: Promising Results on the Role of Cognitive Tele-Rehabilitation Plus Virtual Reality.
Maggio MG; Cannavò A; Quartarone A; Manuli A; Tonin P; Calabrò RS
Brain Sci; 2023 Nov; 13(12):. PubMed ID: 38137084
[TBL] [Abstract][Full Text] [Related]
5. Rehabilitation use in multiple sclerosis: Do illness representations matter?
Glattacker M; Giesler JM; Klindtworth K; Nebe A
Brain Behav; 2018 Jun; 8(6):e00953. PubMed ID: 30106225
[TBL] [Abstract][Full Text] [Related]
6. Health promotion practices in women with multiple sclerosis: increasing quality and years of healthy life.
Stuifbergen AK; Becker H
Phys Med Rehabil Clin N Am; 2001 Feb; 12(1):9-22. PubMed ID: 11853040
[TBL] [Abstract][Full Text] [Related]
7. Health promotion: an essential component of rehabilitation for persons with chronic disabling conditions.
Stuifbergen AK; Rogers S
ANS Adv Nurs Sci; 1997 Jun; 19(4):1-20. PubMed ID: 9161672
[TBL] [Abstract][Full Text] [Related]
8. Rehabilitation of multiple sclerosis patients in India.
Surya N
Ann Indian Acad Neurol; 2015 Sep; 18(Suppl 1):S43-7. PubMed ID: 26538848
[TBL] [Abstract][Full Text] [Related]
9. Cognitive impairment in multiple sclerosis - a review of current knowledge and recent research.
Grzegorski T; Losy J
Rev Neurosci; 2017 Nov; 28(8):845-860. PubMed ID: 28787275
[TBL] [Abstract][Full Text] [Related]
10. Whose Preferences Matter? A Patient-Centered Approach for Eliciting Treatment Goals.
Col NF; Solomon AJ; Springmann V; Garbin CP; Ionete C; Pbert L; Alvarez E; Tierman B; Hopson A; Kutz C; Berrios Morales I; Griffin C; Phillips G; Ngo LH
Med Decis Making; 2018 Jan; 38(1):44-55. PubMed ID: 28806143
[TBL] [Abstract][Full Text] [Related]
11. The effect of exercise training in adults with multiple sclerosis with severe mobility disability: A systematic review and future research directions.
Edwards T; Pilutti LA
Mult Scler Relat Disord; 2017 Aug; 16():31-39. PubMed ID: 28755682
[TBL] [Abstract][Full Text] [Related]
12. The tension between early diagnosis and misdiagnosis of multiple sclerosis.
Solomon AJ; Corboy JR
Nat Rev Neurol; 2017 Sep; 13(9):567-572. PubMed ID: 28799551
[No Abstract] [Full Text] [Related]
13. Alemtuzumab: a review of efficacy and risks in the treatment of relapsing remitting multiple sclerosis.
Guarnera C; Bramanti P; Mazzon E
Ther Clin Risk Manag; 2017; 13():871-879. PubMed ID: 28761351
[TBL] [Abstract][Full Text] [Related]
14. A novel imaging technique for better detecting new lesions in multiple sclerosis.
Eichinger P; Wiestler H; Zhang H; Biberacher V; Kirschke JS; Zimmer C; Mühlau M; Wiestler B
J Neurol; 2017 Sep; 264(9):1909-1918. PubMed ID: 28756606
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus and multiple sclerosis: Updating Pender's hypothesis.
Laurence M; Benito-León J
Mult Scler Relat Disord; 2017 Aug; 16():8-14. PubMed ID: 28755684
[TBL] [Abstract][Full Text] [Related]
16. EBV and MS: Major cause, minor contribution or red-herring?
Burnard S; Lechner-Scott J; Scott RJ
Mult Scler Relat Disord; 2017 Aug; 16():24-30. PubMed ID: 28755681
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic research in multiple sclerosis: progress, challenges, and opportunities.
Zheleznyakova GY; Piket E; Marabita F; Pahlevan Kakhki M; Ewing E; Ruhrmann S; Needhamsen M; Jagodic M; Kular L
Physiol Genomics; 2017 Sep; 49(9):447-461. PubMed ID: 28754822
[TBL] [Abstract][Full Text] [Related]
18. Depression and fatigue in patients with multiple sclerosis.
Greeke EE; Chua AS; Healy BC; Rintell DJ; Chitnis T; Glanz BI
J Neurol Sci; 2017 Sep; 380():236-241. PubMed ID: 28870578
[TBL] [Abstract][Full Text] [Related]
19. Neuroinflammation drives anxiety and depression in relapsing-remitting multiple sclerosis.
Rossi S; Studer V; Motta C; Polidoro S; Perugini J; Macchiarulo G; Giovannetti AM; Pareja-Gutierrez L; Calò A; Colonna I; Furlan R; Martino G; Centonze D
Neurology; 2017 Sep; 89(13):1338-1347. PubMed ID: 28842450
[TBL] [Abstract][Full Text] [Related]
20. Dietary sodium intake: An etiologic dead end in multiple sclerosis.
Koch-Henriksen N; Lauer K
Neurology; 2017 Sep; 89(13):1314-1315. PubMed ID: 28842448
[No Abstract] [Full Text] [Related]
[Next] [New Search]
